AC

Ajay Chintaman Aloni

Active Director Managing Director DIN 08014440
DIN 08014440 First appointment Jan 2018 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jan 2018
Shareholding value •••• Premium profile

About Ajay Chintaman Aloni

Data last updated:

Ajay Chintaman Aloni is a Managing Director at Cellmark India Private Limited (since 2021), Director at Chemiker Pharmaceuticals Private Limited (since 2018) and Director at Toolika Commercials Private Limited (since 2020). The companies operate in Service, Pharma and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹46.68 Cr; the largest is Cellmark India Private Limited at ₹28.84 Cr (FY 2024). Earlier, Ajay Chintaman Aloni was a Director at Asmivilla Hospitality Private Limited (2023–2025) and Director at Tibalaji Petrochem Private Limited (2018–2020).

DIN 08014440
Primary Designation Managing Director
Industry Service
First Appointment 31 Jan 2018
Oldest Company Age 17 yrs
Largest company Cellmark India Private Limited · ₹28.84 Cr (FY 2024)
Combined revenue ₹46.68 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cellmark India Private Limited U72900HR2008FTC123240
Managing Director31 Mar 20212008₹28.84 Cr (FY 2024)Active
Director31 Jan 20182018₹13.39 Cr (FY 2025)Active
Toolika Commercials Private Limited U51909MH2020PTC352710
Director29 Dec 20202020₹4.44 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Nov 20232023Active
Tibalaji Petrochem Private Limited U24299MH2018PTC312643
Director09 Aug 20182018₹395 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemiker Pharmaceuticals Private Limited
Toolika Commercials Private Limited
Cellmark India Private Limited
Asmivilla Hospitality Private Limited
Premium access

Shareholding and investment profile for Ajay Chintaman Aloni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Chintaman Aloni

Ajay Chintaman Aloni currently holds 3 directorships: Cellmark India Private Limited (Managing Director, since 31 Mar 2021, revenue ₹28.84 Cr (FY 2024)); Chemiker Pharmaceuticals Private Limited (Director, since 31 Jan 2018, revenue ₹13.39 Cr (FY 2025)); Toolika Commercials Private Limited (Director, since 29 Dec 2020, revenue ₹4.44 Cr (FY 2025)).

Ajay Chintaman Aloni was first appointed on 31 Jan 2018 as Director at Chemiker Pharmaceuticals Private Limited. The most recent appointment on record is 08 Nov 2023 at Asmivilla Hospitality Private Limited.

The 3 current companies of Ajay Chintaman Aloni that report revenue have a combined latest revenue of ₹46.68 Cr: Cellmark India Private Limited ₹28.84 Cr (FY 2024); Chemiker Pharmaceuticals Private Limited ₹13.39 Cr (FY 2025); Toolika Commercials Private Limited ₹4.44 Cr (FY 2025).

Ajay Chintaman Aloni held 2 earlier board appointments: Asmivilla Hospitality Private Limited (Director, 08 Nov 2023 to 23 Jan 2025); Tibalaji Petrochem Private Limited (Director, 09 Aug 2018 to 03 Oct 2020).

The current boards of Ajay Chintaman Aloni's companies include Ersin Alkan (Cellmark India Private Limited), Jan Rickard Jonsson (Cellmark India Private Limited), Shyam Nanaji Titirmare (Chemiker Pharmaceuticals Private Limited), Smita Aloni (Chemiker Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available